West Pharmaceutical Services to Showcase Innovations at Jefferies Global Healthcare Conference

West Pharmaceutical Services, Inc. (NYSE: WST), a top-tier provider in the realm of injectable drug administration solutions, has recently announced its participation in the upcoming Jefferies Global Healthcare Conference scheduled for November 18, 2026. This annual gathering serves as a significant venue for industry leaders and innovators to present their advancements and insights into the healthcare sector.

The conference will take place at 8:00 AM GMT in London, UK, and will focus on the latest breakthroughs in healthcare, particularly in injectable solutions, which play a critical role in modern medicine. High-quality injectable solutions not only ensure the safe delivery of medications but also enhance the efficacy of treatment protocols for various health conditions.

West is recognized as a leader in this segment, providing essential components and devices that support both established pharmaceutical companies and emerging drug developers. As part of their commitment to enhancing healthcare delivery, West’s solutions ensure that medications are contained and delivered safely, effectively, and efficiently — a key focus area for the company, especially in light of the growing demand for injectable therapeutics.

In a statement released by the company, they emphasized their role as a trusted partner to the pharmaceutical industry. With a commitment to innovation, West continually invests in research and development, striving to enhance their product offerings and support the evolving needs of their clients. “Our innovative solutions are designed not just to meet current demands, but to anticipate future requirements in drug delivery,” the company stated.

The live audio webcast of the Jefferies Global Healthcare Conference will be accessible through West's official website in the 'Investors' section. After the event, a replay of the presentation will be available for an extended period of 90 days, allowing stakeholders and those interested to catch up on the insights shared during the event.

Headquartered in Exton, Pennsylvania, West has built a reputation for excellence, employing over 10,000 people across 50 locations globally, including 26 manufacturing facilities. In the fiscal year 2025, the company reported an impressive $3.07 billion in net sales, affirming its strong position in the market and reflecting its ongoing commitment to providing valuable solutions to their partners.

As the healthcare landscape continues to evolve, West remains at the forefront of innovation, dedicated to delivering high-quality solutions that improve patient outcomes. The company’s participation in the Jefferies conference underscores its ongoing commitment to advancing healthcare and its critical role in the pharmaceutical supply chain.

For more information about West Pharmaceutical Services and its innovative injectable solutions, visit www.westpharma.com.